Marken expands as clients seek to ‘find suitable patients’ in remote areas

By Melissa Fassbender contact

- Last updated on GMT

There are more than 12,000 active clinical trials running in 72 African and Middle Eastern, according to ClinicalTrials.gov. (Image:iStock/Pogonici)
There are more than 12,000 active clinical trials running in 72 African and Middle Eastern, according to ClinicalTrials.gov. (Image:iStock/Pogonici)

Related tags: Clinical trials, Clinical trial, Middle east

Marken has announced it is expanding its offerings to remote areas of the world, as clinical trials become increasingly more complex.

Marken’s clients continue to move to more areas to find suitable patients for their trials​,” Dan Bell, VP Regulatory Compliance and Technical Affairs, told Outsourcing-Pharma.com, who gave the example of Orphan drugs, “for which it is more challenging to find treatment naïve patient population​.”

The company announced it is expanding its reach to areas including Iran, Mongolia, the Azores, the South Pacific Islands, and other remote territories in Eastern Europe and Africa – “in compliance with all relevant regulations​.”

According to the company, these areas continue to emerge as preferred locations for clinical trials because patients previously have historically been limited in their healthcare options.

Clinicaltrials.gov​ cites nearly 12,000 active clinical trials running in 72 African and Middle Eastern countries including Egypt, Israel, Uganda, Jordan, and Kenya.

Recent technology​ advances, such as remote patient monitoring​, have made participating in clinical trials easier, regardless of a patient’s location.

Marken also uses tracking technology, such as the Sentry device and Maestro software, to secure data and shipments and support clinical trials in these regions.

As trial design has become more complex, it is more difficult for our clients to find patients meeting the criteria, hence the obligation to include more remote areas of the world​,” explained Bell.

According to Bell, typical challenges encountered in these remote areas include underdeveloped infrastructure, geopolitical stability, ambiguous regulatory framework, and training of local staff.

To overcome these challenges Bell explained that Marken has developed close relationships with local experts and “work[s] closely with local regulatory bodies to develop best practices​.”

Related news

Show more

Related products

show more

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Follow us

Products

View more

Webinars